LRP6 and metabolic syndrome: Most heterozygous individuals over the age of 45 had clinical manifestations of metabolic syndrome, suggesting that the impact of LRP6 mutation on mulftiple CAD risk factors is important, and the ubiquitous expression of LRP6 gene could explain pleiotropic manifestations in various tissues [69].